Previous research revealed that BTW alleviates experimental colitis by suppressing the IL-6/STAT3 signaling pathway, modulating the Th17/Treg cell balance, and improving microflora structure and bile acid metabolisms (Monteleone et al., 2011; Ma et al., 2018; Wei et al., 2023). The gene discussed is STAT3; the disease is colitis.